Literature DB >> 24355179

Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Daniel Naranjo1, Michal Arkuszewski, Wojciech Rudzinski, Elias R Melhem, Jaroslaw Krejza.   

Abstract

Patients with intracranial hemorrhage have to be managed aggressively to avoid or minimize secondary brain damage due to ischemia, which contributes to high morbidity and mortality. The risk of brain ischemia, however, is not the same in every patient. The risk of complications associated with an aggressive prophylactic therapy in patients with a low risk of brain ischemia can outweigh the benefits of therapy. Accurate and timely identification of patients at highest risk is a diagnostic challenge. Despite the availability of many diagnostic tools, stroke is common in this population, mostly because the pathogenesis of stroke is frequently multifactorial whereas diagnosticians tend to focus on one or two risk factors. The pathophysiological mechanisms of brain ischemia in patients with intracranial hemorrhage are not yet fully elucidated and there are several important areas of ongoing research. Therefore, this review describes physiological and pathophysiological aspects associated with the development of brain ischemia such as the mechanism of oxygen and carbon dioxide effects on the cerebrovascular system, neurovascular coupling and respiratory and cardiovascular factors influencing cerebral hemodynamics. Consequently, we review investigations of cerebral blood flow disturbances relevant to various hemodynamic states associated with high intracranial pressure, cerebral embolism, and cerebral vasospasm along with current treatment options.

Entities:  

Keywords:  brain ischemia; cerebral blood flow; cerebral emboli; cerebral hemodynamics; cerebral ischemia; cerebral perfusion review; cerebral vasospasm; subarachnoid hemorrhage

Mesh:

Year:  2013        PMID: 24355179      PMCID: PMC4202872          DOI: 10.1177/197140091302600603

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  232 in total

1.  Intracranial pressure processing with artificial neural networks: prediction of ICP trends.

Authors:  M Swiercz; Z Mariak; J Krejza; J Lewko; P Szydlik
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

2.  Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

Authors:  A ECKER; P A RIEMENSCHNEIDER
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

3.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  M R Mayberg; H H Batjer; R Dacey; M Diringer; E C Haley; R C Heros; L L Sternau; J Torner; H P Adams; W Feinberg
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

4.  The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study.

Authors:  R P White; C Hindley; P M Bloomfield; V J Cunningham; P Vallance; D J Brooks; H S Markus
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

5.  Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage.

Authors:  T Niemi; P Tanskanen; C Taxell; S Juvela; T Randell; P Rosenberg
Journal:  J Neurosurg Anesthesiol       Date:  1999-07       Impact factor: 3.956

6.  Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion.

Authors:  Alejandro A Rabinstein; Mark A Pichelmann; Jonathan A Friedman; David G Piepgras; Douglas A Nichols; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Jimmy R Fulgham; Fredric B Meyer; John L D Atkinson; Eelco F Wijdicks
Journal:  J Neurosurg       Date:  2003-02       Impact factor: 5.115

7.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

Review 8.  Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.

Authors:  Jan W Dankbaar; Arjen Jc Slooter; Gabriel Je Rinkel; Irene C van der Schaaf
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

9.  Inhibition of nitric oxide synthase attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat.

Authors:  Y Morita-Tsuzuki; J E Hardebo; E Bouskela
Journal:  J Cereb Blood Flow Metab       Date:  1993-11       Impact factor: 6.200

Review 10.  Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis.

Authors:  Ching-Ping Chih; Eugene L Roberts
Journal:  J Cereb Blood Flow Metab       Date:  2003-11       Impact factor: 6.200

View more
  5 in total

1.  Small vessel disease in patients with subarachnoid hemorrhage: Prevalence and associations with vasospasm occurrence, severity and clinical outcomes.

Authors:  Adrien Villain; Grégoire Boulouis; Wagih Ben Hassen; Christine Rodriguez-Regent; Denis Trystram; Myriam Edjlali; François Nataf; Xavier Sauvageon; Tarek Sharshar; Jean F Meder; Catherine Oppenheim; Olivier Naggara
Journal:  Neuroradiol J       Date:  2019-09-30

2.  A nomogram to predict the risk of postoperative intracranial rebleeding in patients with spontaneous intracranial hematoma.

Authors:  Junhua Yang; Yang Liu; Qingyuan Liu; Kaiwen Wang; Shaohua Mo; Maogui Li; Jun Wu; Pengjun Jiang; Shuzhe Yang; Rui Guo; Yi Yang; Jiaming Zhang; Yong Cao; Shuo Wang
Journal:  Neurosurg Rev       Date:  2021-10-29       Impact factor: 3.042

3.  Evaluation of Intracranial Hypertension in Patients With Hypertensive Intracerebral Hemorrhage Using Texture Analysis.

Authors:  Yingchi Shan; Yihua Li; Xiang Wu; Jiaqi Liu; Guoqing Zhang; Yajun Xue; Guoyi Gao
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

4.  Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage.

Authors:  Yuzhen Sun; Baoquan Xu; Qiang Zhang
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

5.  Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models.

Authors:  Wei Li; Tetsuya Asakawa; Sha Han; Baoguo Xiao; Hiroki Namba; Chuanzhen Lu; Qiang Dong; Liang Wang
Journal:  BMC Neurol       Date:  2017-11-07       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.